New York State Psychiatric Institute
New York, 10032, United States
NCT Number: NCT00158184
The purpose of this study is to examine the abuse liability of oxycodone in individuals with, and without, a history of prescription opioid abuse.
Looking for future studies?
Notify Me21 year–45 year
All sexes
Interventional
Phase 2
New York, 10032, United States
Prescription opioid abuse is becoming an increasingly widespread and serious public health concern. The 2001 National Household Survey on Drug Abuse report revealed that the number of first-time users of prescription opioid medications for non-medical reasons reached 2 million in the year 2000, a number that has quintupled since 1984. Despite this trend, little experimental research has been directed towards understanding who may be abusing these medications, and under what conditions. The study will examine the reinforcing, subjective, performance, and physiological effects of oxycodone. Because it is not clear who is abusing prescription opioids, the medication effects will be compared in drug abusers and non-drug abusers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
15 mg/70 kg oxycodone administered once per day, orally.
Other names: immediate-release oxycodone
30 mg/70 kg oxycodone administered once per day, orally.
Other names: immediate-release oxycodone
0 mg placebo dose administered once a day, orally.
Other names: 0 mg
Time frame: Measured at 0, 60, 120, 180 and 240 minutes following administration of each oral oxycodone dose (0 , 15, 30 mg). Results presented as mean of the session
Maximum number of finger presses on a computer mouse completed. The "Breakpoint" is the amount of work (clicks on a mouse) participants were willing to do in order to received the dose of drug under investigation. This is a commonly used indicator of a drugs value and abuse liability.
Time frame: Highest rating obtained following adminstration of each of the 3 test doses.
Subjective rating of drug "Liking" on a scale of 0 to 100. Greater numbers indicate greater subjective report of "Liking."
New York State Psychiatric Institute
Other
Prescription Opioid Effects in Drug and Non-drug Abusers - 1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06023459
Chemically-Induced Disorders, Mental Disorders
El Dorado, Arkansas, United States
View Trial DetailsNCT04567784
Chemically-Induced Disorders, Heroin Abuse
New York, United States
View Trial DetailsNCT04235582
Behavior, Behavior Therapy
Berkeley, California, United States
View Trial DetailsNCT00000319
Chemically-Induced Disorders, Mental Disorders
New Haven, Connecticut, United States
View Trial Details